Company Quick10K Filing
Fulcrum Therapeutics
10-Q 2020-09-30 Filed 2020-11-10
10-Q 2020-06-30 Filed 2020-08-11
S-1 2020-06-22 Public Filing
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-05
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-26
S-1 2019-06-21 Public Filing
8-K 2020-11-10 Earnings, Exhibits
8-K 2020-08-11 Earnings, Exhibits
8-K 2020-07-20 Enter Agreement
8-K 2020-06-24 Other Events
8-K 2020-06-11
8-K 2020-06-09
8-K 2020-05-13
8-K 2020-04-02
8-K 2020-03-05
8-K 2020-01-02
8-K 2019-11-14
8-K 2019-10-04
8-K 2019-08-26
8-K 2019-07-22

Fulcrum Therapeutics Financials

FULC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
GrowGeneration (GRWG) 182,705 29% 57.2 3% 68,417 15,626 54,349 16,008 2,341 2,923 167,194
Technovative Group (TEHG) 182,172 57% -105.6 -33% 5,191 3,101 765 437 -1,719 -1,719 181,597
Exagen (XGN) 182,113 54% -60.9 -3% 92,744 34,094 10,439 5,656 -3,141 -2,132 129,862
Soliton (SOLY) 179,964 -14.9 -130% 9,927 2,745 0 0 -12,896 -11,529 171,255
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420
SWK Holdings (SWKH) 167,159 0% 9.7 6% 247,535 19,907 21,396 0 15,043 16,831 162,673
DOCASA (DCSA) 166,631 24% -117.8 -8% 22,047 6,626 6,454 1,527 -1,773 -1,408 165,842
Jamba (JMBA) 165,009 0% 68.1 -4% 36,654 46,912 78,265 0 -1,563 2,289 155,914
QNB (QNBC) 162,260 5.6 1% 1,245,863 1,126,878 0 0 11,939 25,390 141,473

Balance Sheet ($'000)2019-06-302019-09-30
Cash50,720102,689
Accounts Receivable
Inventory
PP&E12,91713,010
Assets65,151115,956
Accounts Payable3,0814,533
Long-Term Debt
Liabilities11,69613,828
Stockholders' Equity-111,681102,128
Income Statement ($'000)2019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D10,86013,496
SG&A2,6343,510
Tax
Net Income-13,169-16,542
Cash Flow ($'000)2019-06-302019-09-30
Cash Operating-13,017
Cash Investing-214
Cash Financing65,200